Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Conditions
Breast Cancer · Heart Failure
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
Contact: Principal Investigator (Felipe Homem Valle)Irmandade Da Santa Casa De Misericórdia De Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
Contact: Principal Investigator (Katsuki Tiscoski)Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil
Contact: Principal Investigator (Pedro Exman)Clínica de Pesquisa e Centro de Estudos em Oncologia Ginecológica e Mamária Ltda, São Paulo, São Paulo, Brazil
Contact: Principal Investigator (André Mattar)Juravnski Cancer Centre, Hamitlon, Ontario, Canada
Contact: Principal Investigator (Som Mukherjee)Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Contact: Principal Investigator (Marie-France Savard)Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
Contact: Principal Investigator (Dinesh Thavendiranathan)E.Meshalkin National medical research center of the Ministry of Health of the Russian Federation, Novosibirsk, Russia
Study leads
Darryl Leong, PhD. MBBSm
Principal Investigator
McMaster University
Som Mukherjee, MD MSc FRCPC
Principal Investigator
Hamilton Health Sciences Corporation